Multiple Sclerosis
|
0.500 |
Biomarker
|
disease |
BEFREE |
This study investigates the expression of T cell receptor V delta 1 chain, interleukin-2 receptor alpha-chain (CD25) and adhesion molecules ICAM-1 (CD54), LFA-1 (CD11a/18) and CD44 on gamma delta+ T cells by three-color flow cytometry on cerebrospinal fluid (CSF) and blood cells in patients with multiple sclerosis (MS), other inflammatory neurological diseases (OIND) and other neurological diseases (OND).
|
7507498 |
1994 |
Multiple Sclerosis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Examination of activated T cells (CD3+CD25+) isolated from the peripheral blood of MS revealed limited numbers (20 approximately 82) of expanded clones defined by single-strand conformation polymorphism clonotype.
|
9973446 |
1999 |
Multiple Sclerosis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells.
|
15788534 |
2005 |
Multiple Sclerosis
|
0.500 |
Biomarker
|
disease |
BEFREE |
We studied whether changes in the suppressive function of a mixture of CD25(high) and CD25(intemediate) expressing T(reg) cells in myelin basic protein (MBP)-induced proliferation occurred in untreated MS patients.
|
17011048 |
2006 |
Multiple Sclerosis
|
0.500 |
GeneticVariation
|
disease |
GWASCAT |
Risk alleles for multiple sclerosis identified by a genomewide study.
|
17660530 |
2007 |
Multiple Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Of these SNPs, two within the interleukin-2 receptor alpha gene (IL2RA) were strongly associated with multiple sclerosis (P=2.96x10(-8)), as were a nonsynonymous SNP in the interleukin-7 receptor alpha gene (IL7RA) (P=2.94x10(-7)) and multiple SNPs in the HLA-DRA locus (P=8.94x10(-81)).
|
17660530 |
2007 |
Multiple Sclerosis
|
0.500 |
Biomarker
|
disease |
CTD_human |
Risk alleles for multiple sclerosis identified by a genomewide study.
|
17660530 |
2007 |
Multiple Sclerosis
|
0.500 |
GeneticVariation
|
disease |
LHGDN |
Risk alleles for multiple sclerosis identified by a genomewide study.
|
17660530 |
2007 |
Multiple Sclerosis
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Risk alleles for multiple sclerosis identified by a genomewide study.
|
17660530 |
2007 |
Multiple Sclerosis
|
0.500 |
GeneticVariation
|
disease |
LHGDN |
IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.
|
18354419 |
2008 |
Multiple Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.
|
18354419 |
2008 |
Multiple Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A recent genome-wide study showed three additional single-nucleotide polymorphisms (SNPs), within the IL2RA and IL7RA genes respectively, also to be associated with MS.
|
18401352 |
2008 |
Multiple Sclerosis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Recently, large international collaborations provided strong evidence for the involvement of polymorphism of two cytokine receptor genes in the pathogenesis of MS: the interleukin 7 receptor alpha chain gene (IL7RA) on chromosome 5p13 and the interleukin 2 receptor alpha chain gene (IL2RA (=CD25)) on chromosome 10p15.
|
18461312 |
2008 |
Multiple Sclerosis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.
|
18650830 |
2008 |
Multiple Sclerosis
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
The down-regulated 4-1BB expression on CD4+CD25(high) Tregs of MS patients may be involved in the impaired immunoactivity of these Tregs.
|
18727631 |
2008 |
Multiple Sclerosis
|
0.500 |
Biomarker
|
disease |
BEFREE |
To determine whether percentages of CD4(+)CD25(high) T cells (a group of regulatory T cells, Treg) differ in patients with multiple sclerosis (MS) in relapse vs remission after glucocorticoid treatment and whether treatment for relapses changes Treg population and the expression of Foxp3, a key Treg-associated molecule.
|
18771523 |
2009 |
Multiple Sclerosis
|
0.500 |
Biomarker
|
disease |
BEFREE |
IL2RA/CD25, the gene for interleukin-2 receptor alpha, is emerging as a general susceptibility gene for autoimmune diseases because of its role in the development and function of regulatory T cells and the association of single-nucleotide polymorphisms (SNPs) within this gene with type 1 diabetes mellitus (DM), Graves' disease, rheumatoid arthritis (RA), and multiple sclerosis (MS).
|
19116909 |
2009 |
Multiple Sclerosis
|
0.500 |
GeneticVariation
|
disease |
LHGDN |
Here, we report "allelic heterogeneity" at the IL2RA region between MS and T1D.
|
19119414 |
2009 |
Multiple Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Here, we report "allelic heterogeneity" at the IL2RA region between MS and T1D.
|
19119414 |
2009 |
Multiple Sclerosis
|
0.500 |
Biomarker
|
disease |
CTD_human |
Here, we report "allelic heterogeneity" at the IL2RA region between MS and T1D.
|
19119414 |
2009 |
Multiple Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
These findings confirm and extend the association of this gene with MS and reveal a genetic heterogeneity of the associated polymorphisms and risk alleles between MS and T1D suggesting different immunopathological roles of IL2RA in these two diseases.
|
19125193 |
2009 |
Multiple Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
These data indicate that, in addition to specific allelic variants at IL2RA, immunological perturbations associated with aggressive forms of the disease can influence sIL-2RA levels in serum of MS subjects.
|
19155502 |
2009 |
Multiple Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Together these results confirm involvement of polymorphisms in the IL7RA and IL2RA genes in MS pathogenesis and suggest that IL7RA variation may primarily affect chronic disease courses.
|
19231135 |
2009 |
Multiple Sclerosis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Functional investigations suggest a potential mechanism whereby increases in CD58 expression, mediated by the protective allele, up-regulate the expression of transcription factor FoxP3 through engagement of the CD58 receptor, CD2, leading to the enhanced function of CD4(+)CD25(high) regulatory T cells that are defective in subjects with MS.
|
19237575 |
2009 |
Multiple Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
These data provide further evidence of allelic heterogeneity at the IL2RA locus and point to the existence of at least two independent MS susceptibility alleles.
|
19375175 |
2009 |